Keyphrases
Travellers
100%
Israel
76%
Israeli
48%
Developing Countries
36%
Travel-related
29%
Epidemiology
23%
Human African Trypanosomiasis
21%
Blood Donors
21%
Hospitalization
21%
Chronic Illness
21%
Human T-cell Leukemia Virus Type 1 (HTLV-1)
21%
Vaccinia Virus
21%
Neutralizing Antibodies
21%
Africa
19%
Malaria
16%
Travel Companies
15%
Retrospective Cohort Study
14%
Primaquine
14%
Asia
12%
Febrile Disease
12%
Atovaquone-proguanil
12%
Dosing Errors
10%
Nepal
10%
Revaccination
10%
Adult Hospital
10%
Non-endemic Countries
10%
Urinary Retention
10%
Serum Uric Acid
10%
Mineral Oil
10%
Bezoar
10%
Formation Kinetics
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Diagnostic pitfalls
10%
Unilateral Pulmonary Edema
10%
Life-limiting Conditions
10%
Pregnancy Outcome
10%
Course of Pregnancy
10%
Acute Diarrhea
10%
Diarrhea
10%
Tick-borne Encephalitis
10%
Human Cost
10%
Potential Drug Interactions
10%
North America
10%
Lipoid Pneumonia
10%
Anachronism
10%
American Students
10%
Biowarfare Agents
10%
International Travellers
10%
Malignant Disease
10%
Environmental Shedding
10%
Medicine and Dentistry
Disease
52%
Returning Traveler
34%
Cohort Effect
23%
Infection
21%
African Trypanosomiasis
21%
Traveller Diarrhea
15%
Fever
14%
Tropical Disease
14%
Retrospective Cohort Study
13%
Diagnosis
13%
Atovaquone/Proguanil
12%
Coxiella burnetii
10%
Drug Therapy
10%
Diarrhea
10%
Urinary Retention
10%
Drug Interaction
10%
Acute Diarrhea
10%
Consultation
10%
Transesophageal Echocardiography
10%
Bezoar
10%
Infective Endocarditis
10%
Patient Referral
10%
Pulmonary Edema
10%
Combination Therapy
10%
Tick Borne Encephalitis
10%
Chemoprophylaxis
10%
Ipratropium Bromide
10%
Blood Donor
10%
Mineral Oil
10%
Premature Labor
10%
Lipid Pneumonia
10%
Fibroelastoma
10%
Endocarditis
10%
Ceftriaxone
10%
Antimalarial Agent
10%
Human T-Lymphotropic Virus 1
10%
Travel Medicine
10%
Chronic Disease
10%
Salmonella Enterica Serovar Paratyphi A
10%
Dengue Fever
10%
Azithromycin
9%
Leishmaniasis
9%
Pulsed Field Gel Electrophoresis
7%
Papillary Fibroelastoma
7%
Dermatological Disease
7%
Monotherapy
7%
Schistosomiasis
7%
Cutaneous Leishmaniasis
6%
Laxative
6%
Gastrointestinal Distress
6%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
32%
Primaquine
18%
Azithromycin
14%
Atovaquone Plus Proguanil
14%
Toxic Injury
13%
Cohort Study
13%
Bezoar
10%
Infection
10%
Diabetes Mellitus
10%
Uric Acid
10%
Vaccinia Virus
10%
Acute Diarrhea
10%
Acetazolamide
10%
Neutralizing Antibody
10%
Diarrhea
10%
Human T-Lymphotropic Virus 1
10%
Drug Interaction
10%
Chronic Disease
10%
Salmonella Enterica Serovar Paratyphi A
10%
Ceftriaxone
10%
Tetrazolium
10%
Ipratropium Bromide
10%
Urine Retention
10%
Virus Encephalitis
10%
Encephalitis
8%
Drug Intolerance
7%
Monotherapy
7%
Pulsed-Field Gel Electrophoresis
7%
Mefloquine
7%
Prevalence
6%
Formazan
5%
Trichobezoar
5%
